Current Directions in Biomedical Engineering (Sep 2022)

Biological test methods for stents: cellular responses to microstructured biomaterials

  • Klußmann-Fricke Bastian-Jesper,
  • Stahnke Thomas,
  • Siewert Stefan,
  • Reske Thomas,
  • Bohne Eric,
  • Schmitz Klaus-Peter,
  • Khaimov Valeria

DOI
https://doi.org/10.1515/cdbme-2022-1100
Journal volume & issue
Vol. 8, no. 2
pp. 392 – 395

Abstract

Read online

One of the greatest challenges in the development of novel implants is to find materials that optimally interact with the tissue and support the function of the implant over a long period of time. Especially considering the fact that biomaterials are used in multiple applications in modern implants, a better understanding of the physiology of the tissue in contact with the material becomes more and more important. To better understand the cellular responses to biomaterials, it is furthermore necessary that the models used reflect the physiological conditions at the implant site. However, in most cases, immortalized cell lines instead of tissue-specific primary cells are used to study the biocompatibility of implant materials. When interpreting these results, it is important to consider that cell lines differ significantly from primary cells found in their native environment. In this study, we examined the morphological differences between a cell line and primary cells upon contact with various implant structures resembling implant prototypes. Using a mouse fibroblast cell line in comparison with primary porcine fibroblasts, we discuss the results with respect to the use of cell lines for biocompatibility testing of biomaterials. Our results suggest that to better estimate meaningful results regarding the compatibility of implant structures, key control experiments should always be performed with specific primary cells.

Keywords